126456-36-8

Basic information

• Product Name: tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]carbamate
• CAS NO: 126456-36-8
• Molecular Formula: C₃₃H₄₀N₂O₅
• Molecular Weight: 544.6811
• Mol File: 126456-36-8.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 795.5°C at 760 mmHg
• Flash Point: 434.9°C
• Density: 1.22g/cm³
• Vapor Pressure: 1.09E-26mmHg at 25°C
• Refractive Index: 1.615
• CAS DataBase Reference: tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]carbamate(126456-36-8)
• EPA Substance Registry System: tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]carbamate(126456-36-8)

Safety Data

• Hazardous Substances Data: 126456-36-8(Hazardous Substances Data)

Usage

General Description

Tert-butyl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]carbamate is a complex chemical compound with multiple functional groups. It contains a tert-butyl group, a dibenzyl group, a hydroxy group, an amino group, and a carbamate group. The compound has a chiral center and specific stereochemistry. Overall, it is a carbamate derivative with a bulky tert-butyl group attached to a pentyl chain, which in turn is connected to a hydroxyindane moiety and a dibenzylamine group, making it a potentially interesting molecule for further study in medicinal chemistry or related fields.

Upstream product

• 147912-04-7 [(1S,2S,4R)-1-Benzyl-2-(tert-butyl-dimethyl-silanyloxy)-4-(2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-carbamic acid tert-butyl ester 
• 7480-35-5 trans-1-aminoindan-2-ol 
• 141018-42-0 [(1S,2S,4R)-1,4-Dibenzyl-5-((3aS,8aR)-2,2-dimethyl-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-3-yl)-2-hydroxy-5-oxo-pentyl]-carbamic acid tert-butyl ester 
• 98818-41-8 (3R,5S)-3-benzyl-5-{(1S)-1-[(tert-butoxycarbonyl)amino]-2-phenylethyl}dihydrofuran-2-(3H)-one 
• 98818-51-0 N-(1,1-dimethylethoxycarbonyl)-5(S)-amino-4(S)-(t-butyldimethylsilyloxy)-6-phenyl-2(R)-(phenylmethyl)hexanoic acid 
• 72155-45-4 Boc-L-phenylalaninal 
• 98818-48-5 C₃₆H₅₉NO₅Si₂ 
• 7480-35-5 (1S,2R)-1-amino-2-indanol 
• 98818-42-9 (3S,5S)-3-benzyl-5-{(1S)-1-[(tert-butoxycarbonyl)amino]-2-phenylethyl}dihydrofuran-2-(3H)-one 
• 565454-73-1 (1,4-dibenzyl-2-oxo-pent-4-enyl)-carbamic acid tert-butyl ester 
• 63516-03-0 α-bromo-p-toluidine 
• 193338-94-2 (5S,1'S)-carbetoxy-5-<1-<<(1',1-dimethylothoxy)carbonyl>amino>-2-phenylmethyl>dihydrofuran-2(3H)-one 
• 98760-08-8 (2R,3S)-3-[N-(tert-butyloxycarbonyl)amino]-1,2-epoxy-4-phenylbutane 
• 141018-37-3 (3aS,8aR)-2,2-dimethyl-3-(3-phenylpropanoyl)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d][1,3]oxazole 

Downstream Products

• 145631-04-5 [(1S,2S,4R)-1-Benzyl-2-hydroxy-4-((1S,2R)-2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-carbamic acid cyclopentyl ester 
• 145631-03-4 [(1S,2S,4R)-1-Benzyl-2-hydroxy-4-((1S,2R)-2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-carbamic acid (R)-(tetrahydro-furan-3-yl) ester 
• 145631-03-4 N-(2(R)-hydroxy-1(S)-indanyl)-5(S)-(3(S)-tetrahydrofuranyloxycarbonylamino)-4(S)-hydroxy-6-phenyl-2(R)-phenylmethyl hexanamide 
• 145631-05-6 [(1S,2S,4R)-1-Benzyl-2-hydroxy-4-((1S,2R)-2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-carbamic acid (R)-(tetrahydro-pyran-3-yl) ester 
• 145631-05-6 [(1S,2S,4R)-1-Benzyl-2-hydroxy-4-((1S,2R)-2-hydroxy-indan-1-ylcarbamoyl)-5-phenyl-pentyl]-carbamic acid (S)-(tetrahydro-pyran-3-yl) ester 

Relevant articles and documents

Allyltrichlorostannane additions to α-amino aldehydes: Application to the total synthesis of the aspartyl protease inhibitors L-682,679, L-684,414, L-685,434, and L-685,458

The hydroxyethylene dipeptide isosteres L-682,679, L-684,414, L-685,434, and L-685,458 were synthesized in a few steps by a sequence involving an allyltrichlorostannane coupling with an α-amino aldehyde, followed by hydroboration of the corresponding 1,2-

HIV protease inhibitors useful for the treatment of aids

Compounds of the form,ψ ψ A-G-Jψ ψ wherein A is an amine protecting group or urethane, G a dipeptide isostere and J a small terminal group are described. They are distinguished by tetrahydrofuryl or tetrahydropyranyl substituents, and the like. These compounds are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.ψ

HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: An investigation into the role of the P1' side chain on structure-activity

A systematic investigation was undertaken to determine the role of the P1' sidechain in a series of hydroxyethylene isostere based inhibitors of HIV-1 protease. Substitution and homologation of the benzyl P1' side chain of the Phe-Phe isostere based pseudo peptides 1 (L-682,679) and 2 (L-685,434) with various heteroalkyl groups leads to a series of extremely potent inhibitors of the enzyme. Several examples of the most potent inhibitors were very effective in an ex vivo cell based viral spread assay using human H9 T- lymphocytes and the IIIb isolate of HIV-1. Compound 19 is 120 times more potent than 1 and 16 times more potent than 2 in inhibiting the spread of infection in this assay.